Neurostimulation Devices Market By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electric Stimulators), By Therapeutic Areas (Pain Management, Epilepsy, Essential Tremors, Urinary And Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease) - Growth, Future Prospects & Competitive Analysis, 2016 - 2024

Neurostimulation is the process of agitating or modulating the neural activities for therapeutic purpose. Neurostimulation devices are used for neuromodulation and function by either stimulating nerve impulses of inhibiting pain signals at specific sites such as the autonomic nervous system, peripheral nervous system, deep nuclei of brain or the central nervous system. Significant growth in geriatric population base has triggered the incidence of age related nervous conditions such as Alzheimer’s disease and Parkinson’s disease, and has thereby presented an area of high unmet medical needs in neurological disease segments. Similar scenario is also experienced in other conditions such as chronic pain, migraine, epilepsy and others. Going forward, it is expected that the growth of neurostimulation devices market will be facilitated by efficient harnessing of the untapped market opportunities in Asia Pacific and Latin America markets further evolution in neurostimulation treatments.

This report attempts to study the global neurostimulation devices market in terms of product types, therapeutic areas, and regional distribution. Based on product types, this report studies individual markets for spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator and gastric electric stimulator. Whereas, in terms of therapeutic areas, the report studies global neurostimulation devices market for pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, parkinson's disease and other therapeutic areas. Market size and forecast for each mentioned segment are provided in this report for the period 2013-2024 (US$ Mn), along with respective CAGR (value %) for the period 2016-2024.

Geographically, the neurostimulation devices market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Market size and respective forecast for these regional and country level markets are presented in this study for the period 2013-2024. Market growth rates for the forecast period 2016-2024 are also included in this report, considering 2015 as the base year. This study also includes cross-sectional market size and forecast for each regional market thus considered by product types, and therapeutic areas.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global neurostimulation devices market. Tools such as market positioning of key players, and attractive investment proposition provide the readers with insights on the competitive scenario of the global neurostimulation devices market. This report concludes with company profiles section that highlights major information about the key players engaged in development, manufacture and sales of neurostimulation devices.

Neurostimulation Devices Market

For the purpose of this study, the global neurostimulation devices market is categorized as follows:

  • North America (U.S., Canada)
  • Europe (U.K., Germany, Rest of Europe)
  • Asia Pacific (Japan, China, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)

Neurostimulation Devices Market

North America accounted for the largest revenue share in the global neurostimulation devices market. However, the region is expected to lose its market share to rapid developments in European and Asia Pacific markets, stringent regulatory policies in the U.S. and yet retain its dominance during the forecast period. In addition, presence of large unmet needs in Asia and Latin America will make the manufacturers to shift their focus from North America and Western Europe and allow the fastest market growth rates to these regions. Improving disposable incomes of the general population and awareness about availability of latest treatments for neurodegenerative diseases are anticipated to be chief environmental factors prevalent in the region. Existence of significantly large patient population base will also further drive the market growth in Asia Pacific.

Choose License Type
Published Date:  Jan 2017
Category:  Medical Devices
Report ID:   58336
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Connect With Us
+1-408-641-3282
24/7 Research Support